drugset / Trial / NCT00095017

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

NCT00095017

Phase 2 Withdrawn Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of an investigational drug versus placebo in the treatment of metastatic bone cancer pain in patients diagnosed with breast or prostate cancer and a bone neoplasm. Patients in the study will be taking opioids to treat moderate to severe pain for their bone metastases and will remain on their opioids during the entire course of the study.

Timeline

Start
2004-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 90 mg

Indications